Prause, M., Niedermoser, S., Wängler, C., Seibold, U., Riester, S., Fricker, G., & Wängler, B. (2018). Synthesis, in vitro and in vivo evaluation of 18F-fluoronorimatinib as radiotracer for Imatinib-sensitive gastrointestinal stromal tumors. Nuclear medicine and biology, 57, . https://doi.org/10.1016/j.nucmedbio.2017.11.004
Chicago-Zitierstil (17. Ausg.)Prause, Martin, Sabrina Niedermoser, Carmen Wängler, Uwe Seibold, Stephanie Riester, Gert Fricker, und Björn Wängler. "Synthesis, in Vitro and in Vivo Evaluation of 18F-fluoronorimatinib as Radiotracer for Imatinib-sensitive Gastrointestinal Stromal Tumors." Nuclear Medicine and Biology 57 (2018). https://doi.org/10.1016/j.nucmedbio.2017.11.004.
MLA-Zitierstil (9. Ausg.)Prause, Martin, et al. "Synthesis, in Vitro and in Vivo Evaluation of 18F-fluoronorimatinib as Radiotracer for Imatinib-sensitive Gastrointestinal Stromal Tumors." Nuclear Medicine and Biology, vol. 57, 2018, https://doi.org/10.1016/j.nucmedbio.2017.11.004.